HLN Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
NYSE:HLN

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 7, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$HLN N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Haleon plc Loading... Loading...
Sector Name Loading... N/A

Related

TEVATeva Pharmaceutical Industries Limited-0.6%
BHCBausch Health Companies Inc.1.0%
ZTSZoetis Inc.1.7%
TAKTakeda Pharmaceutical Company Limited-0.1%
RDYDr. Reddy's Laboratories Limited1.1%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue8,480M9,892M9,545M10,858M11,302M
Growth Rate-16.7%-3.5%13.8%4.1%
EBITDA1,176M1,905M1,951M2,163M2,814M
EBITDA Margin13.9%19.3%20.4%19.9%24.9%
Net Income655M1,145M1,390M1,060M1,049M
NI Margin7.7%11.6%14.6%9.8%9.3%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.